Clinical Trial Update: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating safety and efficacy of Pozelimab with Cemdisiran combination and Cemdisiran alone in adults with Generalized Myasthen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Cemdisiran (cemdisiran)
• Pozelimab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: ACTIVE_NOT_RECRUITING